Home › Cancer (all types) › NCT02749474

Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes

Maternal Cancer Diagnosis and Treatment During Pregnancy:a Registry for Maternal, Fetal, and Neonatal Outcomes With Longitudinal Follow up of Child Development and Maternal Psychological Well Being

Who can join

All ages · Women · Healthy volunteers welcome

Inclusion Criteria:

* Any pregnant woman diagnosed with cancer within 6 weeks before her last menstrual period or 6 months after her end of pregnancy either by delivery or miscarriage.

Exclusion Criteria:

* Women diagnosed with cancer more than 6 months after the end of a pregnancy.

About the study

The objective of this study is to follow the treatment options offered to pregnant women diagnosed with cancer and study the impact that their treatment or delay of treatment has on their own health and that of their children.

Sponsor: Cooper Norcross Health · Participants: 400 · Started: Jul 1, 2003

Contact the study team

• Elyce H Cardonick, MD · Phone: 856342 2065
• Harry Mazurek · Phone: 8563422000

Official record on ClinicalTrials.gov — NCT02749474

Locations in the U.S.

Conditions

• Cancer (all types)

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.